Перейти до основного вмісту
Підтримка для батьків від ЮНІСЕФ Україна
  • Дізнатись більше
UNICEF Logo Europe and Central Asia
  • English
  • русский

Global Links

  • Visit UNICEF Global
  • Висока контрастність
UNICEF Logo Europe and Central Asia
    • EXPLORE UNICEF
      • About us
      • Our mandate
      • Regional Director
      • The situation for children
      • Where we work
      • Our Voices: Young people from the Region
      • Ambassadors and Supporters
      • Partners
  • Press centre

Main navigation Ukrainian language

  • What we do
  • Research and reports
  • Stories
  • Take action
Search area has closed.
Search area has opened.
ПОШУКЗакрити

Пошук по сайту ЮНІСЕФ

  • Доступно:
  • English
  • русский
  • Українська
  • Polish
  • Slovak
  • Czech
Знайдено 4
  • (-) Заява (2)
  • (-) Нотатка (2)
  • Прес-реліз (4)
  • Стаття (1)
  • #ENDviolence (1)
  • (-) COVAX (4)
  • COVID-19 (9)
  • Імунізація (6)
  • Вакцини (4)
  • Виконавчий директор (1)
  • Вчителі (1)
  • Гендерне насильство (1)
  • Грудне вигодовування (1)
  • Гуманітарні дії та надзвичайні ситуації (2)
  • Збройний конфлікт (2)
  • Здоров'я (3)
  • Здоров'я матері (1)
  • Справедливість (1)
  • ECARO (1)
  • Глобальний (3)
News note
11 Лютий 2021
UNICEF signs supply agreement for Pfizer/BioNTech COVID-19 vaccine
https://www.unicef.org/eca/press-releases/unicef-signs-supply-agreement-pfizerbiontech-covid-19-vaccine
NEW YORK, 11 February 2021: UNICEF announced today the signing of an agreement with Pfizer on behalf of the COVAX Facility for the supply of the Pfizer-BioNTech COVID-19 Vaccine through 2021.  Deliveries of the vaccine are anticipated to start as early as the first quarter of 2021, once the countries that were allocated Pfizer-BioNTech vaccine…
Statement
10 Лютий 2021
In the COVID-19 vaccine race, we either win together or lose together
https://www.unicef.org/eca/press-releases/covid-19-vaccine-race-we-either-win-together-or-lose-together
NEW YORK/GENEVA, 10 February 2021 – “Of the 128 million vaccine doses administered so far, more than three quarters of those vaccinations are in just 10 countries that account for 60 per cent of global GDP. “As of today, almost 130 countries, with 2.5 billion people, are yet to administer a single dose. “This self-defeating strategy will cost…
Statement
15 Грудень 2020
Teachers should be prioritized for vaccination against COVID-19
https://www.unicef.org/eca/press-releases/teachers-should-be-prioritized-vaccination-against-covid-19
NEW YORK, 15 December 2020 – “The COVID-19 pandemic has wreaked havoc on children’s education around the globe. Vaccinating teachers is a critical step towards putting it back on track.  “At their peak in late April 2020, nationwide school closures disrupted the learning of almost 90 per cent of students worldwide. While that number has dropped…
News note
16 Червень 2021
UNICEF signs supply agreement for Sputnik V COVID-19 vaccine
https://www.unicef.org/eca/press-releases/unicef-signs-supply-agreement-sputnik-v-covid-19-vaccine
NEW YORK/COPENHAGEN, 27 May 2021 -  UNICEF and Human Vaccine (Limited Liability Company), a wholly-owned subsidiary of the Russian Direct Investment Fund (RDIF), today announced a long-term agreement (LTA) for the supply of the Sputnik V COVID-19 vaccine. This is the fourth long-term supply agreement UNICEF has signed with a COVID-19 vaccine manufacturer. So far this year, UNICEF has signed such agreements with the Serum Institute of India, Pfizer and AstraZeneca. Procurement by UNICEF under this agreement is conditional on the product achieving an Emergency Use Listing from WHO, to confirm the quality, safety and efficacy of the vaccine.  In addition, an Advance Purchase Agreement (APA) with Gavi, the Vaccine Alliance, will also be needed for procurement to begin on behalf of the COVAX Facility. Should the COVAX Facility decide to enter into an advance purchase agreement for the supply of the Sputnik V vaccine, UNICEF will be ready to deliver as soon as regulatory milestones have been met. At this point, UNICEF through this LTA, stands ready to access up to 220 million doses of the vaccine available for supply in 2021, to meet country demand.  The Sputnik V vaccine consists of two different components of the vaccine to be administered 21 days apart. An exact delivery schedule will be determined in collaboration with the manufacturer. UNICEF’s priority is to make sure that all countries have safe, fast and equitable access to COVID-19 vaccine and to help them prepare for the rollout of immunization.  The best way to bring the pandemic under control is to ensure that safe and effective vaccines are made available as widely as possible and as quickly as possible, reducing inequity by ensuring that no country or territory is left behind due to its economic status. On 24 February 2021, COVID-19 vaccine vials are produced for the COVAX facility at a manufacturer in Pune, a city located in the western Indian state of Maharashtra. UNICEF/UN0421679?Singh

Footer Ukrainian language

UNICEF Home
  • Situation for children
  • What we do
  • Where we work
Data, Research and Reports
  • Ambassadors and Supporters
  • Partners
  • Publications

Social

Footer secondary Ukrainian language

  • Contact us
  • Legal